Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June - 1 July 2024.

Lambach, Philipp; Silal, Sheetal; Sbarra, Alyssa N; Crowcroft, Natasha S; Frey, Kurt; Ferrari, Matt; Vynnycky, Emilia; Metcalf, C Jessica E; Winter, Amy K; Zimmerman, Laura; +12 more... Koh, Mitsuki; Sheel, Meru; Kim, Sun-Young; Munywoki, Patrick K; Portnoy, Allison; Aggarwal, Rakesh; Farooqui, Habib Hasan; Flasche, Stefan; Hogan, Alexandra B; Leung, Kathy; Moss, William J; Wang, Xuan-Yi; (2024) Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June - 1 July 2024. Vaccine, 42 (26). 126307-. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2024.126307

Abstract

The World Health Organization's Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC) serves to independently review and evaluate vaccine-related research to maximize the potential impact of vaccination programs. From 28 June - 1 July 2024, IVIR-AC was convened for an ad hoc meeting to discuss new evidence on criteria for rubella vaccine introduction and the risk of congenital rubella syndrome. This report summarizes background information on rubella virus transmission and the burden of congenital rubella syndrome, meeting structure and presentations, proceedings, and recommendations.

Additional Information

Item Type	Article
Faculty and Department	Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology & Dynamics (2023-)
Research Centre	Centre for the Mathematical Modelling of Infectious Diseases
PubMed ID	39276622
Elements ID	229558
Official URL	http://dx.doi.org/10.1016/j.vaccine.2024.126307